Navitas Life Sciences rapidly mobilized its digital resources during the COVID-19 pandemic to ensure the smooth transition into remote work.
The rise in healthcare costs spirals down into a subsequent rise in the Gross Domestic Product (GDP) of every country, forcing stakeholders to scrutinize
Pharmacovigilance (PV) is fundamental to the pharmaceutical industry, and it continues to grow in size, with new challenges and inclusions for safety reporting.
The Global Regulatory Management system was valued at US$ 797.2 million in 2018, with a projected yearly CAGR of nearly 14% from 2019 to 2027.
There have been significant strides in health care innovation, with a better understanding of underlying biology and identification
The COVID-19 pandemic provided a glimpse of how important health and associated healthcare is, to individuals in particular,
Digital innovation has been revolutionizing clinical trials, and has made virtual trials possible. A critical element and driver has been
There are decisive signs to show, for the first time, that the world is taking an upper hand in the fight against COVID-19,
In 2020, the value of the global regulatory affairs outsourcing market size was 6.3 billion,
The vaccines that are being steadily rolled out across the globe have raised significant hopes of the pandemic reaching a turning point.